CX3CR1 and attention deficit-hyperactivity disorder: The beneficial effects of the MPH treatment on microglial activation and CX3CR1 levels observed in the ADHD model are in accordance with our previous study, in the brain [4], where we demonstrated a decrease in microglial reactivity in the ADHD model after treatment with MPH (1.5 mg/kg).